Lepu Historical Income Statement

300003 Stock

12.18 0.29 2.44%

Historical analysis of Lepu Medical income statement accounts such as Selling General Administrative of 1.1 B, Total Revenue of 4.7 B or Operating Income of 1.3 B can show how well Lepu Medical Tech performed in making a profits. Evaluating Lepu Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Lepu Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Lepu Medical Tech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lepu Medical Tech is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lepu Medical Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Lepu Income Statement Analysis

Lepu Medical Tech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Lepu Medical shareholders. The income statement also shows Lepu investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Lepu Medical Income Statement Chart

At present, Lepu Medical's Net Income Applicable To Common Shares is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 441.6 M, whereas Interest Expense is forecasted to decline to about 100 M.

Selling General Administrative Total Revenue Operating Income Cost Of Revenue

Total Revenue

Total revenue comprises all receipts Lepu Medical Tech generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Operating Income

Operating Income is the amount of profit realized from Lepu Medical Tech operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Lepu Medical Tech is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Lepu Medical Tech income statement and represents the costs associated with goods and services Lepu Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Lepu Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Lepu Medical Tech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lepu Medical Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Operating Income	2.7B	2.9B	1.8B	1.3B
Total Revenue	10.7B	10.6B	8.0B	4.7B

Operating Income Total Revenue

Lepu Medical income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Research Development	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		0.88	0.9	0.8	0.88	0.87	0.74	0.32	0.75	0.87	0.7	0.83	0.77	0.81	0.21	0.84	-0.88	0.52	0.62	0.54
Total Revenue	0.88		0.99	0.98	0.97	0.97	0.87	0.1	0.95	0.96	0.91	0.93	0.94	0.96	0.43	0.92	-0.62	0.79	0.85	0.83
Operating Income	0.9	0.99		0.96	0.99	0.99	0.85	0.12	0.92	0.97	0.88	0.95	0.92	0.95	0.4	0.94	-0.67	0.74	0.82	0.78
Cost Of Revenue	0.8	0.98	0.96		0.93	0.92	0.84	0.04	0.95	0.92	0.9	0.89	0.92	0.95	0.48	0.89	-0.49	0.78	0.83	0.85
Income Before Tax	0.88	0.97	0.99	0.93		1.0	0.84	0.19	0.91	0.95	0.86	0.97	0.89	0.93	0.44	0.94	-0.69	0.71	0.81	0.77
Net Income	0.87	0.97	0.99	0.92	1.0		0.84	0.16	0.91	0.96	0.86	0.97	0.89	0.93	0.45	0.94	-0.69	0.72	0.82	0.77
Income Tax Expense	0.74	0.87	0.85	0.84	0.84	0.84		0.01	0.91	0.92	0.92	0.87	0.93	0.91	0.58	0.9	-0.44	0.86	0.91	0.88
Minority Interest	0.32	0.1	0.12	0.04	0.19	0.16	0.01		-0.07	0.0	-0.07	0.07	-0.05	-0.11	-0.19	0.01	-0.43	-0.26	-0.17	-0.28
Research Development	0.75	0.95	0.92	0.95	0.91	0.91	0.91	-0.07		0.95	0.96	0.92	0.97	0.97	0.61	0.92	-0.45	0.88	0.95	0.95
Gross Profit	0.87	0.96	0.97	0.92	0.95	0.96	0.92	0.0	0.95		0.91	0.97	0.95	0.98	0.48	0.97	-0.64	0.81	0.88	0.85
Other Operating Expenses	0.7	0.91	0.88	0.9	0.86	0.86	0.92	-0.07	0.96	0.91		0.85	0.98	0.93	0.64	0.88	-0.41	0.91	0.96	0.93
Net Income From Continuing Ops	0.83	0.93	0.95	0.89	0.97	0.97	0.87	0.07	0.92	0.97	0.85		0.88	0.95	0.52	0.98	-0.64	0.73	0.84	0.82
Ebit	0.77	0.94	0.92	0.92	0.89	0.89	0.93	-0.05	0.97	0.95	0.98	0.88		0.95	0.53	0.89	-0.5	0.92	0.95	0.91
Total Operating Expenses	0.81	0.96	0.95	0.95	0.93	0.93	0.91	-0.11	0.97	0.98	0.93	0.95	0.95		0.55	0.97	-0.54	0.84	0.91	0.91
Total Other Income Expense Net	0.21	0.43	0.4	0.48	0.44	0.45	0.58	-0.19	0.61	0.48	0.64	0.52	0.53	0.55		0.61	-0.03	0.49	0.68	0.71
Tax Provision	0.84	0.92	0.94	0.89	0.94	0.94	0.9	0.01	0.92	0.97	0.88	0.98	0.89	0.97	0.61		-0.63	0.73	0.86	0.83
Net Interest Income	-0.88	-0.62	-0.67	-0.49	-0.69	-0.69	-0.44	-0.43	-0.45	-0.64	-0.41	-0.64	-0.5	-0.54	-0.03	-0.63		-0.21	-0.37	-0.22
Interest Income	0.52	0.79	0.74	0.78	0.71	0.72	0.86	-0.26	0.88	0.81	0.91	0.73	0.92	0.84	0.49	0.73	-0.21		0.94	0.92
Ebitda	0.62	0.85	0.82	0.83	0.81	0.82	0.91	-0.17	0.95	0.88	0.96	0.84	0.95	0.91	0.68	0.86	-0.37	0.94		0.96
Reconciled Depreciation	0.54	0.83	0.78	0.85	0.77	0.77	0.88	-0.28	0.95	0.85	0.93	0.82	0.91	0.91	0.71	0.83	-0.22	0.92	0.96

Click cells to compare fundamentals

Lepu Medical Account Relationship Matchups

Lepu Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	321.7M	268.9M	228.5M	188.8M	170.6M	100.0M
Selling General Administrative	2.4B	2.0B	2.4B	1.5B	1.1B	1.1B
Total Revenue	7.8B	8.0B	10.7B	10.6B	8.0B	4.7B
Operating Income	2.3B	2.2B	2.7B	2.9B	1.8B	1.3B
Cost Of Revenue	2.2B	2.7B	4.2B	4.0B	2.9B	1.6B
Income Before Tax	2.1B	2.2B	2.1B	2.6B	1.6B	1.2B
Net Income Applicable To Common Shares	1.2B	1.7B	1.8B	1.7B	2.0B	2.1B
Net Income	1.7B	1.8B	1.7B	2.2B	1.3B	1.0B
Income Tax Expense	219.0M	339.5M	326.2M	365.7M	420.6M	441.6M
Minority Interest	522.2M	664.6M	(61.1M)	(42.3M)	(34.2M)	(32.4M)
Research Development	543.9M	736.1M	907.9M	957.1M	879.4M	562.7M
Gross Profit	5.6B	5.4B	6.5B	6.6B	5.1B	5.0B
Other Operating Expenses	56.5M	91.6M	82.6M	103.1M	118.6M	77.7M
Net Income From Continuing Ops	1.7B	1.9B	1.8B	2.2B	1.3B	1.5B
Ebit	1.7B	2.2B	2.1B	2.6B	3.0B	1.8B
Total Operating Expenses	5.5B	5.9B	8.0B	7.8B	6.1B	5.6B
Tax Provision	339.5M	326.2M	365.7M	365.7M	262.1M	305.9M
Net Interest Income	(286.7M)	(239.7M)	(178.3M)	(108.7M)	(59.6M)	(62.5M)
Interest Income	44.4M	43.2M	57.6M	88.0M	115.3M	60.6M
Ebitda	2.7B	2.9B	2.8B	3.3B	3.8B	2.8B
Reconciled Depreciation	284.5M	388.2M	448.7M	488.5M	513.6M	402.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in Lepu Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lepu Historical Income Statement

About Lepu Income Statement Analysis

Lepu Medical Income Statement Chart

Total Revenue

Operating Income

Cost Of Revenue

Lepu Medical income statement Correlations

Lepu Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Lepu Medical income statement Accounts

Also Currently Popular

Other Information on Investing in Lepu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 1.0	Income Before Tax
Operating Income	+ 0.99	Total Revenue
Income Before Tax	+ 0.99	Operating Income
Net Income	+ 0.99	Operating Income
Cost Of Revenue	+ 0.98	Total Revenue
Total Operating Expenses	+ 0.98	Gross Profit

Net Interest Income	- 0.88	Selling General Administrative
Net Interest Income	- 0.69	Net Income
Net Interest Income	- 0.69	Income Before Tax
Net Interest Income	- 0.67	Operating Income
Net Interest Income	- 0.64	Net Income From Continuing Ops
Net Interest Income	- 0.64	Gross Profit